1. Home
  2. LXRX vs GMHS Comparison

LXRX vs GMHS Comparison

Compare LXRX & GMHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LXRX
  • GMHS
  • Stock Information
  • Founded
  • LXRX 1995
  • GMHS N/A
  • Country
  • LXRX United States
  • GMHS China
  • Employees
  • LXRX N/A
  • GMHS N/A
  • Industry
  • LXRX Biotechnology: Pharmaceutical Preparations
  • GMHS
  • Sector
  • LXRX Health Care
  • GMHS
  • Exchange
  • LXRX Nasdaq
  • GMHS NYSE
  • Market Cap
  • LXRX 124.4M
  • GMHS 106.1M
  • IPO Year
  • LXRX 2000
  • GMHS N/A
  • Fundamental
  • Price
  • LXRX $0.51
  • GMHS $1.19
  • Analyst Decision
  • LXRX Buy
  • GMHS
  • Analyst Count
  • LXRX 4
  • GMHS 0
  • Target Price
  • LXRX $3.67
  • GMHS N/A
  • AVG Volume (30 Days)
  • LXRX 32.2M
  • GMHS 280.3K
  • Earning Date
  • LXRX 05-01-2025
  • GMHS 01-01-0001
  • Dividend Yield
  • LXRX N/A
  • GMHS N/A
  • EPS Growth
  • LXRX N/A
  • GMHS 98.09
  • EPS
  • LXRX N/A
  • GMHS 0.05
  • Revenue
  • LXRX $31,081,000.00
  • GMHS $145,236,749.00
  • Revenue This Year
  • LXRX N/A
  • GMHS N/A
  • Revenue Next Year
  • LXRX $63.36
  • GMHS N/A
  • P/E Ratio
  • LXRX N/A
  • GMHS $23.80
  • Revenue Growth
  • LXRX 2481.48
  • GMHS N/A
  • 52 Week Low
  • LXRX $0.28
  • GMHS $0.96
  • 52 Week High
  • LXRX $2.45
  • GMHS $17.49
  • Technical
  • Relative Strength Index (RSI)
  • LXRX 53.30
  • GMHS N/A
  • Support Level
  • LXRX $0.48
  • GMHS N/A
  • Resistance Level
  • LXRX $0.60
  • GMHS N/A
  • Average True Range (ATR)
  • LXRX 0.09
  • GMHS 0.00
  • MACD
  • LXRX 0.01
  • GMHS 0.00
  • Stochastic Oscillator
  • LXRX 42.86
  • GMHS 0.00

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.

About GMHS GAMEHAUS HOLDINGS INC

Gamehaus Holdings Inc is a technology-driven mobile game publishing company for small- and medium-sized game developers. It built a diverse game portfolio across multiple genres, including social casino, match, simulation, RPG, puzzle, and bingo, others, and distributes mobile games created by developer partners across a wide range of gaming markets, including in countries such as the U.S., the U.K., Australia, Germany, France, Canada, Brazil, Japan, and India, among others. The company offers a comprehensive package of services covering all aspects of the game life cycle, including (i) game development, (ii) screening and pre-publication testing, (iii) user acquisition, and (iv) monetization.

Share on Social Networks: